Historical record. CMS lists this CCN as terminated (voluntary - merger/closure). No successor CCN is recorded. The financials below are the historical results reported under this number and are excluded from current peer comparisons and state counts.
Cost-report basis
HCRIS · as filed
Not audited by Astrelis
The read
A hospice in TX. It ran an operating surplus of 7.6% in FY24 on $1.0M of operating revenue. It held 57 days of cash on hand. Only a single comparable reporting year is available, so trend context is limited.
Days cash on hand · FY24
57d
all sources
vs hospices—
Total operating revenue · FY24
$1.0M
vs hospices—
Operating margin · FY24
+7.6%
vs hospices—
Total days of care
6094.0d
Verified fact2024
Source: HCRIS CMS-1984
Where BAYOU HOSPICE LLC sits among hospices
Operating margin · FY24 pool · n = 3,488 of 5,626 filed
Each point is one hospice in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The hospice median is +0.1%. Descriptive context only, not a ranking.
One hospiceBAYOU HOSPICEhospice median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this hospice is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
+7.6% (FY24)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+7.6% (FY24)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
57d (FY24)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
Not shown, outside plausibility bounds
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
21% (FY24)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
Not reported in this filing
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
quality & operational context · CMS public reporting
The metrics this hospice type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Routine home care mix
99.9%
Verified fact2024
HCRIS CMS-1984
Respite mix
0.1%
Verified fact2024
HCRIS CMS-1984
Total days of care
6094.0d
Verified fact2024
HCRIS CMS-1984
Continuous home care mix
0.0%
Verified fact2024
HCRIS CMS-1984
General inpatient mix
0.0%
Verified fact2024
HCRIS CMS-1984
Trajectory
Cost-report basis · 2 reporting years
Operating margin
Days cash on hand
The county this hospice serves
Location, TX
Median household income
$113.4K
vs $82.1K US · $59.7K rural median
Poverty rate
7.2%
vs 12.5% US · 14.3% rural median
Uninsured
11.9%
vs 8.6% US · 8.4% rural median
Age 65+
12.2%
vs 16.8% US · 20.6% rural median
Fair or poor health
17.0%
self-reported, adults · CDC PLACES
Primary-care shortage
Designated
HRSA HPSA
Economic context: 3.4% of county personal income is Medicare/Medicaid medical benefits; 10.4% arrives as government transfers (BEA, 2022).
Opportunity screen · FY24
≈ $136K
of annual opportunity identified against peer medians across 1 measure
Directional, conservative band. Arithmetic against matched-peer medians from public filings, not a projection; public data cannot fully control for patient acuity.
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
Where this facility is underperforming its matched peer cohort and what that gap is worth, measure by measure. Founding Edition: delivered within 30 days of eligibility confirmation, full refund if the published scope cannot be delivered.
